
    
      This is a phase III, multi-centre, prospective, randomized, active-controlled, assessor-blind
      study. Primary endpoint: percentage of time of adequately maintained sedation, in absence of
      rescue sedation, within the COMFORT-B interval (light, moderate, or deep sedation) prescribed
      at randomization, monitored every 2 hours for an expected minimum of 12 hours (up to 48
      hours).
    
  